866-997-4948(US-Canada Toll Free)

Global Meningococcal Vaccines Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 110 Pages

This report studies the global market size of Meningococcal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Vaccines in these regions.
This research report categorizes the global Meningococcal Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Meningococcal Vaccines market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Meningococcal Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of Meningococcal Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Meningococcal Vaccines include
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International

Market Size Split by Type
Menactra
Menomune
Market Size Split by Application
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Meningococcal Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Meningococcal Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Meningococcal Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Meningococcal Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Meningococcal Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Meningococcal Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Meningococcal Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Meningococcal Vaccines Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Meningococcal Vaccines Market Size Growth Rate by Type
1.4.2 Menactra
1.4.3 Menomune
1.5 Market by Application
1.5.1 Global Meningococcal Vaccines Market Size Growth Rate by Application
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Bacteremia
1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Meningococcal Vaccines Market Size
2.1.1 Global Meningococcal Vaccines Revenue 2016-2025
2.1.2 Global Meningococcal Vaccines Sales 2016-2025
2.2 Meningococcal Vaccines Growth Rate by Regions
2.2.1 Global Meningococcal Vaccines Sales by Regions
2.2.2 Global Meningococcal Vaccines Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Meningococcal Vaccines Sales by Manufacturers
3.1.1 Meningococcal Vaccines Sales by Manufacturers
3.1.2 Meningococcal Vaccines Sales Market Share by Manufacturers
3.1.3 Global Meningococcal Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Meningococcal Vaccines Revenue by Manufacturers
3.2.1 Meningococcal Vaccines Revenue by Manufacturers (2016-2018)
3.2.2 Meningococcal Vaccines Revenue Share by Manufacturers (2016-2018)
3.3 Meningococcal Vaccines Price by Manufacturers
3.4 Meningococcal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Vaccines Product Category
3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Meningococcal Vaccines Sales by Type
4.2 Global Meningococcal Vaccines Revenue by Type
4.3 Meningococcal Vaccines Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Meningococcal Vaccines Breakdown Data by Application

6 North America
6.1 North America Meningococcal Vaccines by Countries
6.1.1 North America Meningococcal Vaccines Sales by Countries
6.1.2 North America Meningococcal Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Meningococcal Vaccines by Type
6.3 North America Meningococcal Vaccines by Application
6.4 North America Meningococcal Vaccines by Company

7 Europe
7.1 Europe Meningococcal Vaccines by Countries
7.1.1 Europe Meningococcal Vaccines Sales by Countries
7.1.2 Europe Meningococcal Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningococcal Vaccines by Type
7.3 Europe Meningococcal Vaccines by Application
7.4 Europe Meningococcal Vaccines by Company

8 Asia Pacific
8.1 Asia Pacific Meningococcal Vaccines by Countries
8.1.1 Asia Pacific Meningococcal Vaccines Sales by Countries
8.1.2 Asia Pacific Meningococcal Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Meningococcal Vaccines by Type
8.3 Asia Pacific Meningococcal Vaccines by Application
8.4 Asia Pacific Meningococcal Vaccines by Company

9 Central & South America
9.1 Central & South America Meningococcal Vaccines by Countries
9.1.1 Central & South America Meningococcal Vaccines Sales by Countries
9.1.2 Central & South America Meningococcal Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Meningococcal Vaccines by Type
9.3 Central & South America Meningococcal Vaccines by Application
9.4 Central & South America Meningococcal Vaccines by Company

10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Vaccines by Countries
10.1.1 Middle East and Africa Meningococcal Vaccines Sales by Countries
10.1.2 Middle East and Africa Meningococcal Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Meningococcal Vaccines by Type
10.3 Middle East and Africa Meningococcal Vaccines by Application
10.4 Middle East and Africa Meningococcal Vaccines by Company

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Meningococcal Vaccines
11.1.4 Meningococcal Vaccines Product Description
11.1.5 Recent Development
11.2 JN-International Medical
11.2.1 JN-International Medical Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Meningococcal Vaccines
11.2.4 Meningococcal Vaccines Product Description
11.2.5 Recent Development
11.3 Novartis International
11.3.1 Novartis International Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Meningococcal Vaccines
11.3.4 Meningococcal Vaccines Product Description
11.3.5 Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Meningococcal Vaccines
11.4.4 Meningococcal Vaccines Product Description
11.4.5 Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Meningococcal Vaccines
11.5.4 Meningococcal Vaccines Product Description
11.5.5 Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Meningococcal Vaccines
11.6.4 Meningococcal Vaccines Product Description
11.6.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Meningococcal Vaccines Raw Material
13.1.2 Meningococcal Vaccines Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Meningococcal Vaccines
Figure Global Meningococcal Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Meningococcal Vaccines Production Market Share by Types (Product Category) in 2017
Figure Menactra Product Picture
Table Major Manufacturers of Menactra
Figure Menomune Product Picture
Table Major Manufacturers of Menomune
Table Global Meningococcal Vaccines Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Pneumonia
Figure Meningitis
Figure Bacteremia
Figure Others (Arthritis, Conjunctivitis, Urethritis)
Figure Meningococcal Vaccines Report Years Considered
Figure Global Meningococcal Vaccines Market Size 2016-2025 (Million US$)
Figure Global Meningococcal Vaccines Sales 2016-2025 (K Units)
Table Global Meningococcal Vaccines Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Meningococcal Vaccines Sales by Regions 2016-2025 (K Units)
Table Global Meningococcal Vaccines Sales Market Share by Regions 2016-2025
Figure Global Meningococcal Vaccines Sales Market Share by Regions 2016-2025
Figure 2017 Global Meningococcal Vaccines Sales Market Share by Regions
Table Global Meningococcal Vaccines Revenue by Regions 2016-2025 (Million US$)
Table Global Meningococcal Vaccines Revenue Market Share by Regions 2016-2025
Figure Global Meningococcal Vaccines Revenue Market Share by Regions 2016-2025
Figure 2017 Global Meningococcal Vaccines Revenue Market Share by Regions
Table Global Meningococcal Vaccines Sales by Manufacturers (2016-2018) (K Units)
Table Global Meningococcal Vaccines Sales Share by Manufacturers (2016-2018)
Figure Global Meningococcal Vaccines Sales Share by Manufacturers in 2017
Table Meningococcal Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
Table Meningococcal Vaccines Revenue Share by Manufacturers (2016-2018)
Figure Meningococcal Vaccines Value Share by Manufacturers in 2017
Table Global Meningococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Meningococcal Vaccines Price (2016-2018) (USD/Unit)
Table Meningococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Meningococcal Vaccines Product Category
Table Date of International Manufacturers Enter into Meningococcal Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Meningococcal Vaccines Sales by Type (2016-2025) (K Units)
Table Global Meningococcal Vaccines Sales Share by Type (2016-2025)
Figure Global Meningococcal Vaccines Sales Market Share by Type (2016-2025)
Figure Global Meningococcal Vaccines Sales Market Share by Type in 2017
Table Global Meningococcal Vaccines Revenue by Type (2016-2025) (Million US$)
Table Global Meningococcal Vaccines Revenue Share by Type (2016-2025)
Figure Global Meningococcal Vaccines Revenue Market Share by Type (2016-2025)
Figure Global Meningococcal Vaccines Revenue Market Share by Type in 2017
Table Meningococcal Vaccines Price by Type 2013-2018 (USD/Unit)
Table Global Meningococcal Vaccines Sales by Application (2016-2025) (K Units)
Table Global Meningococcal Vaccines Sales Share by Application (2016-2025)
Figure Global Sales Meningococcal Vaccines Market Share by Application (2016-2025)
Figure Global Sales Meningococcal Vaccines Market Share by Application (2016-2025)
Figure North America Meningococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure North America Meningococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table North America Meningococcal Vaccines Sales by Countries (2016-2025) (K Units)
Table North America Meningococcal Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 North America Meningococcal Vaccines Sales Market Share by Countries
Table North America Meningococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
Table North America Meningococcal Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Meningococcal Vaccines Revenue Market Share by Countries
Figure United States Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure United States Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Canada Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table North America Meningococcal Vaccines Sales by Type (2016-2025) (K Units)
Table North America Meningococcal Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 North America Meningococcal Vaccines Market Share by Type
Table North America Meningococcal Vaccines Sales by Application (2016-2025) (K Units)
Table North America Meningococcal Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 North America Meningococcal Vaccines Market Share by Application
Table North America Meningococcal Vaccines Sales by Company (2016-2018) (K Units)
Table North America Meningococcal Vaccines Sales Market Share by Company (2016-2018)
Figure North America Meningococcal Vaccines Sales Market Share by Company in 2017
Figure Europe Meningococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Europe Meningococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Meningococcal Vaccines Sales by Countries (2016-2025) (K Units)
Table Europe Meningococcal Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Meningococcal Vaccines Sales Market Share by Countries
Table Europe Meningococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Europe Meningococcal Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Meningococcal Vaccines Revenue Market Share by Countries
Figure Germany Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Germany Meningococcal Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure France Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure France Meningococcal Vaccines Revenue Growth Rate (2016-2025) (K Units)
Figure UK Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure UK Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Italy Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Russia Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Meningococcal Vaccines Sales by Type (2016-2025) (K Units)
Table Europe Meningococcal Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Europe Meningococcal Vaccines Market Share by Type
Table Europe Meningococcal Vaccines Sales by Application (2016-2025) (K Units)
Table Europe Meningococcal Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Europe Meningococcal Vaccines Market Share by Application
Table Europe Meningococcal Vaccines Sales by Company (2016-2018) (K Units)
Table Europe Meningococcal Vaccines Sales Market Share by Company (2016-2018)
Figure Europe Meningococcal Vaccines Sales Market Share by Company in 2017
Figure Asia Pacific Meningococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Meningococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Meningococcal Vaccines Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Meningococcal Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Meningococcal Vaccines Sales Market Share by Countries
Table Asia Pacific Meningococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Meningococcal Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Meningococcal Vaccines Revenue Market Share by Countries
Figure China Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure China Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Japan Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Korea Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure India Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure India Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Australia Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Meningococcal Vaccines Sales by Type (2016-2025) (K Units)
Table Asia Pacific Meningococcal Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Meningococcal Vaccines Market Share by Type
Table Asia Pacific Meningococcal Vaccines Sales by Application (2016-2025) (K Units)
Table Asia Pacific Meningococcal Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Meningococcal Vaccines Market Share by Application
Table Asia Pacific Meningococcal Vaccines Sales by Company (2016-2018) (K Units)
Table Asia Pacific Meningococcal Vaccines Sales Market Share by Company (2016-2018)
Figure Asia Pacific Meningococcal Vaccines Sales Market Share by Company in 2017
Figure Central & South America Meningococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Meningococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Meningococcal Vaccines Sales by Countries (2016-2025) (K Units)
Table Central & South America Meningococcal Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Meningococcal Vaccines Sales Market Share by Countries
Table Central & South America Meningococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Meningococcal Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Meningococcal Vaccines Revenue Market Share by Countries
Figure Brazil Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Meningococcal Vaccines Sales by Type (2016-2025) (K Units)
Table Central & South America Meningococcal Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Meningococcal Vaccines Market Share by Type
Table Central & South America Meningococcal Vaccines Sales by Application (2016-2025) (K Units)
Table Central & South America Meningococcal Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Meningococcal Vaccines Market Share by Application
Table Central & South America Meningococcal Vaccines Sales by Company (2016-2018) (K Units)
Table Central & South America Meningococcal Vaccines Sales Market Share by Company (2016-2018)
Figure Central & South America Meningococcal Vaccines Sales Market Share by Company in 2017
Figure Middle East and Africa Meningococcal Vaccines Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Meningococcal Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Meningococcal Vaccines Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Vaccines Sales Market Share by Countries
Table Middle East and Africa Meningococcal Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Meningococcal Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Vaccines Revenue Market Share by Countries
Figure GCC Countries Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Meningococcal Vaccines Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Meningococcal Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Meningococcal Vaccines Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Vaccines Market Share by Type
Table Middle East and Africa Meningococcal Vaccines Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Vaccines Market Share by Application
Table Middle East and Africa Meningococcal Vaccines Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Meningococcal Vaccines Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Meningococcal Vaccines Sales Market Share by Company in 2017
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table JN-International Medical Company Details
Table JN-International Medical Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table JN-International Medical Recent Development
Table Novartis International Company Details
Table Novartis International Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis International Recent Development
Table Sanofi Company Details
Table Sanofi Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Baxter International Company Details
Table Baxter International Meningococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Baxter International Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Meningococcal Vaccines Value Chain
Table Typical Suppliers of Key Meningococcal Vaccines Raw Material
Table Meningococcal Vaccines Customers List
Table Meningococcal Vaccines Sales Channels
Table Meningococcal Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *